---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-004345"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T15:08:44.466058+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# PAVmed elects to receive $4.68M in Lucid common stock for management fees

## Summary
- PAVmed issued 3,331,771 shares of Lucid common stock in lieu of $4,675,256 in fees and reimbursements.
- Fees accrued under management services and payroll reimbursement agreements from Oct 1, 2022 to Dec 31, 2022.
- PAVmed will distribute the shares to its stockholders on or before February 15, 2024.
- This unregistered equity issuance follows terms previously disclosed in the MSA and PBERA.

## SEC filing metadata
- accession: 0001493152-24-004345
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000149315224004345/0001493152-24-004345-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000149315224004345/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-004345
- JSON: https://secwatch.observer/filing/0001493152-24-004345.json
- Plain text: https://secwatch.observer/filing/0001493152-24-004345.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.